CYMBALTA® (duloxetine hydrochloride) is an oral medication belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) class.

Cephalexin, also known as KEFLEX®, is a semisynthetic cephalosporin antibacterial drug that works by inhibiting PBPs.

TESSALON® (Benzonatate), a non-narcotic cough medicine by Pfizer Inc., was FDA-approved in the US in 1958.

Metformin Hydrochloride, sold under the trade name GLUCOPHAGE, is a medication used in the treatment of type 2 diabetes mellitus.

ZOFRAN® (Ondansetron Hydrochloride) is a medication used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and postoperative nausea and/or vomiting.

Cozaar® (losartan potassium) is a drug for treating hypertension, left ventricular hypertrophy, and type 2 diabetes-related nephropathy.

Melatonin is a small molecule drug that acts on melatonin receptors, functioning as an agonist.

CBR-701 (SYS6002), a cutting-edge therapeutic agent aimed at Nectin-4, exhibits promising outcomes in initial human trials with Nectin-4 positive cancer patients.

Naproxen is a small molecule drug that inhibits COX enzymes, with active indications including pain, gout, inflammation, ankylosing spondylitis, and juvenile arthritis.

Famotidine is a medicine that helps people with stomach problems like gastritis and peptic ulcers.

Flare Therapeutics Unveils Design for FX-909's Early-Stage Trial with Dose Increasing and Widening Approach at ASCO's 2024 Urologic Cancer Conference.

Amoxicillin Trihydrate is a cell wall inhibitor drug used as an antibiotic to treat bacterial infections like bronchitis, pneumonia, urinary tract infections, and strep throat.